Israel’s Immunity Pharma had positive results from its Phase 2a human trial with IPL344 in amyotrophic lateral sclerosis (ALS) patients. Disease progression compared to placebo slowed by some 50% over 3 years. There were other positive indications and no serious … Continue reading →

Israel-based NGO Ezer Mizion now has over 1.1 million potential donors on its global database. Its stem cell transplants have now saved 5,000+ lives – almost 500 in 2023. Its support services provide hot meals, medical equipment, family and mental … Continue reading →

A clinic dealing with post-trauma and related mental-health disorders was planned to be inaugurated in Tel Aviv University in about two years’ time. But due to the urgent need for treatment following Oct7, it has now been launched on temporary … Continue reading →

Before the Brazilian President’s hateful speech, his country’s medical authorities approved the home ultrasound system from Israel’s Pulsenmore (see here previously) for use in reducing pre-natal fatalities and unnecessary visits to hospital by pregnant mothers. https://www.prnewswire.com/il/news-releases/pulsenmore-receives-brazilian-anvisa-approval-for-its-prenatal-home-ultrasound-solution-302030148.html

The US FDA has granted “orphan” status on BX004 from Israel’s BiomX (see here previously) for the treatment of chronic lung infections suffered by cystic fibrosis patients. Orphan designation is given for rare conditions that have no current treatment. https://ir.biomx.com/news-events/press-releases/detail/101/biomx-receives-orphan-drug-designation-from-the-u-s-food

The US FDA has just granted Breakthrough Device status to Israel’s PI-Cardia (see here previously) for its ShortCut ™ device that facilitates Transcatheter Aortic Valve Replacement (TAVR) procedures. https://www.businesswire.com/news/home/20240122184265/en/Pi-Cardia-Receives-FDA-Breakthrough-Device-Designation-for-ShortCut%E2%84%A2

Researchers at the Hebrew University of Jerusalem (HU) have developed a new method of analyzing pancreatic cell types and help discover diabetes early. Their DNA methylation-based analysis is far more accurate than current analysis that relies on protein markers. https://www.afhu.org/2024/02/12/new-study-by-hebrew-university-researchers-addresses-an-alternative-to-traditional-protein-marker-diabetes-detection/ … Continue reading →